Abcell-bio arose from the will to accompany research by facilitating the access to primary resources which are difficult to get, especially cells from cord blood.
Every year, we hear about Pink October and Movember, but Red September isn’t as widely recognized. This month is dedicated to raising awareness for blood
Abcell-bio is searching for a talented and dedicated lab technician who would become part of our developing production unit. The candidates will be responsible for
Abcell-bio offers an M2 internship position for its R&D project on isolated CD34+ cells from cord blood. Duties: The goal is to optimize and develop new
This article describe a new humanized mice model that is a unique tool for investigating, in vivo, the biology of Plasmodium vivax, the most widespread human malaria
Although umbilical cord blood (UCB) is a promising source of Hematopoietic stem and progenitor cells (HSPCs), the low dose of HSPCs in these preparations limits
This article describe a new humanized mice model that is a unique tool for investigating, in vivo, the biology of Plasmodium vivax, the most widespread human malaria
This study aims at investigating the co-implantation of human adipose-derived stem cells (ADSCs) after osteogenic differentiation and human umbilical vein endothelial cells (HUVECs) embedded in
Biotechnology laboratory, Abcell-bio produces quality primary human cells from perinatal tissues. Our team is made up of dedicated scientists, whose objective is to facilitate the
Umbilical cord blood (UCB) is a rich source of hematopoietic stem cells (HSCs). Comparatively, UCB HSCs have an extensive proliferative capacity that exceeds that of